Dr. Tareq Salous, MD

Dr. Salous practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Salous' NPI, 1306367156, was assigned on July 2, 2017. Dr. Salous holds Indiana license 01083851A.

Dr. Salous' primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Salous' primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Salous is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Salous to 3 more hospitals, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salous practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Salous' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Salous is licensed in Indiana.

CMS data shows 538 Medicare services from Dr. Salous across 6 procedure codes in 2024, for 140 Medicare patients. Medicare paid $38,289 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Salous in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 71% have cancer. 13% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salous' median patient age at 66, with 22% women.

In 2024, Dr. Salous wrote 564 Medicare Part D claims for 81 patients. 81% of them were for generic drugs. CMS names the drug for 384 of them, across 14 drugs with 11 or more claims each, at $826,086 in total drug cost. In 2020, CMS named 130 claims across 8 drugs.

Dr. Salous accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salous as offering telehealth.

Dmand AI links 7 papers to Dr. Salous, published from 2019 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Brain Neoplasms and Testicular Neoplasms. Dr. Salous has published most often in Curr Opin Oncol. Dr. Salous' most frequent co-authors are Nabil Adra, MD, Danielle M. Brander, MD and Michael Youngjun Choi, MD.

CMS Open Payments shows 15 general payments to Dr. Salous from 10 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 94% of the total. Seagen Inc. paid the most, $436.